TransEnterix

At TransEnterix, our vision is to improve clinical outcomes and patient care through the use of robotics in surgery. We seek to enhance and support surgeon capabilities while reducing the barriers to adoption with responsible economics and leveraging existing laparoscopic skills. SurgiBot™ and ALF-X® create a robotics portfolio that allows us to offer both a single-port and a multi-port platform. Our technology utilizes robotic assistance to enhance surgery with precision, dexterity, vision and ergonomics. Both platforms are designed to utilize laparoscopic experience while addressing the cost barriers of robotic surgery. The combined offerings of SurgiBot and ALF-X allow TransEnterix to address a broad range of procedures, facilities and geographies with compelling patient, surgeon and hospital value. SurgiBot™ and ALF-X® create a robotics portfolio that allows us to offer both a single-port and a multi-port platform. Our technology utilizes robotic assistance to enhance surgery with precision, dexterity, vision and ergonomics. Both platforms are designed to utilize laparoscopic experience while addressing the cost barriers of robotic surgery. The combined offerings of SurgiBot and ALF-X allow TransEnterix to address a broad range of procedures, facilities and geographies with compelling patient, surgeon and hospital value. The SurgiBot System is not available for sale in any market. The ALF-X has received the CE mark but is not available for sale in the U.S.
Company Growth (employees)
Type
Public
HQ
Morrisville, US
Founded
2006
Size (employees)
103 (est)-20%
TransEnterix was founded in 2006 and is headquartered in Morrisville, US

Key People at TransEnterix

Todd M. Pope

Todd M. Pope

President & CEO
Jane H. Hsiao

Jane H. Hsiao

Chairman of the Board
Charles J. Filipi

Charles J. Filipi

M.D.

TransEnterix Office Locations

TransEnterix has offices in Morrisville and Trezzano Rosa
Morrisville, US (HQ)
300 635 Davis Dr
Trezzano Rosa, IT
40 Via Firenze

TransEnterix Data and Metrics

TransEnterix Financial Metrics

TransEnterix's revenue was reported to be $1.5 m in FY, 2016
Numbers are in $, USD

Revenue (FY, 2016)

1.5 m

Gross profit (FY, 2016)

450 k

Gross profit margin (FY, 2016), %

30%

Net income (FY, 2016)

(120 m)

EBIT (FY, 2016)

(123.6 m)

Market capitalization (28-Apr-2017)

79.8 m

Closing share price (28-Apr-2017)

1.1

Cash (31-Dec-2016)

24.2 m
TransEnterix's current market capitalization is $79.8 m.
Numbers are in $, USDFY, 2013FY, 2014FY, 2015FY, 2016

Revenue

1.4 m401 k1.5 m

Revenue growth, %

(72%)(100%)

Cost of goods sold

4.8 m1.1 m1.1 m

Gross profit

(3.4 m)(694 k)450 k

Gross profit Margin, %

(236%)(173%)30%

Operating expense total

22.2 m35.9 m46.4 m124.1 m

EBIT

(25.6 m)(36.6 m)(46.4 m)(123.6 m)

EBIT margin, %

(1789%)(9129%)(8140%)

Interest expense

954 k1 m1.6 m1.9 m

Pre tax profit

(28.4 m)(37.7 m)(48 m)(125.5 m)

Income tax expense

2.8 m1 m1 m5.5 m

Net Income

(28.4 m)(37.7 m)(46.9 m)(120 m)
Numbers are in $, USDFY, 2013FY, 2014FY, 2015FY, 2016

Cash

10 m34.8 m38.4 m24.2 m

Accounts Receivable

188 k133 k76 k621 k

Inventories

3.9 m7.9 m

Current Assets

17.8 m35.7 m49.1 m38 m

PP&E

1.9 m3.1 m4.4 m5.8 m

Goodwill

93.8 m93.8 m130.9 m68.7 m

Total Assets

116.7 m135.2 m248.6 m176.2 m

Accounts Payable

1.8 m1.8 m4.5 m4 m

Current Liabilities

7.1 m4.1 m31.1 m30.7 m

Additional Paid-in Capital

203 m257.6 m363.3 m426.6 m

Retained Earnings

(98.3 m)(135.9 m)(182.9 m)(302.8 m)

Total Equity

105 m121.8 m177.3 m117.9 m

Financial Leverage

1.1 x1.1 x1.4 x1.5 x
Numbers are in $, USDFY, 2013FY, 2014FY, 2015FY, 2016

Net Income

(28.4 m)(37.7 m)(46.9 m)(120 m)

Depreciation and Amortization

1.5 m1.3 m2.2 m7 m

Accounts Receivable

402 k55 k133 k(1 m)

Inventories

731 k701 k(1.9 m)(6.6 m)

Accounts Payable

641 k(36 k)1.1 m(356 k)

Cash From Operating Activities

1.1 m(33.4 m)(38.8 m)(52.4 m)

Purchases of PP&E

(1.4 m)(2.2 m)(1.2 m)(1.4 m)

Cash From Investing Activities

(6.5 m)4 m(26.2 m)(1.4 m)

Cash From Financing Activities

53.9 m68.4 m49.9 m

Interest Paid

824 k904 k973 k1.3 m
Y, 2016

Financial Leverage

1.5 x

TransEnterix Operating Metrics

TransEnterix's Patents Issued was reported to be 19 in FY, 2016
FY, 2016

Patent Applications

40

Patents Issued

19

TransEnterix Market Value History

TransEnterix Online and Social Media Presence

TransEnterix Company Life and Culture

You may also be interested in